NVIC Says BMJ Review Demonstrates Medical Journal Bias Toward Pharma-Sponsored Influenza Vaccine Studies
Main Category: Flu / Cold / SARSAlso Included In: Pharma Industry / Biotech Industry; Public Health
Article Date: 16 Feb 2009 - 4:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
In a review of influenza vaccine studies published in the British Medical Journal Tom Jefferson, M.D., Ph.D. (Cochrane Field, Rome, Italy) and colleagues found that published influenza vaccine studies sponsored by industry are treated more favorably by medical journals even when the studies are of poor quality. "This independent Cochrane review confirms that drug companies marketing vaccines have undue influence on what gets published in medical journals about vaccine safety and effectiveness," said Barbara Loe Fisher, president of the National Vaccine Information Center (NVIC), a non-profit vaccine safety watchdog group that earlier this week issued a new report on Gardasil vaccine risks.
Jefferson and his colleagues identified and assessed 274 published studies on influenza vaccines for their methodological quality and found no relationship between study quality, publication in prestige journals or their subsequent citation in other articles. They also found that most influenza vaccine studies are of poor quality but those with conclusions favorable to influenza vaccinations are of significantly lower methodological quality. The single most important factor determining where the studies were published or how much they were cited was sponsorship, with those partially or wholly funded by the pharmaceutical industry having higher visibility.
Dr. Jefferson commented, "The study shows that one of the levers for accessing prestige journals is the financial size of your sponsor. Pharma sponsors order many reprints of studies supporting their products, often with in house translations into many languages. They also purchase advertising space in the journal. Many publishers openly advertise these services on their website. It is time journals made a full disclosure of their sources of funding."
The National Vaccine Information Center is calling on the Obama Administration and Congress to investigate Gardasil vaccine risks and has long questioned the inappropriate influence of vaccine manufacturers in federal vaccine licensing and policymaking and state vaccine mandates.
For more information on the BMJ study "Relation of study quality, concordance, take home message, funding and impact in studies of influenza vaccines: a systematic review," visit http://www.BMJ.com or http://www.NVIC.org.
National Vaccine Information Center
Visit our flu / cold / sars section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/139150.php>
APA
http://www.medicalnewstoday.com/releases/139150.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



